Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of...

Keywords

PDGFRBPDGFRAEosinophiliaMyeloidFusion geneCancer researchMyeloid leukemiaTyrosine kinaseTyrosine-kinase inhibitorMedicineBiologyInternal medicineCancerGeneticsGeneReceptorGiST

Affiliated Institutions

Munich Leukemia Laboratory (Germany) DE

Related Publications

Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene

Elisa Rumi , Jelena D. Milosevic Feenstra , Dominik Selleslag +11 more

2015 Annals of Hematology 59 citations

Should myeloid and lymphoid neoplasms with <i><scp>PCM</scp>1‐<scp>JAK</scp>2</i> and other rearrangements of <i><scp>JAK</scp>2</i> be recognized as specific entities?

Barbara J. Bain , Shahzaib Ahmad

Summary Since the publication of the 2001 and 2008 World Health Organization classifications of tumours of haematopoietic and lymphoid tissues, there has been an increasing move...

2014 British Journal of Haematology 83 citations

Publication Info

Year: 2013
Type: article
Volume: 92
Issue: 6
Pages: 759-769
Citations: 50
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                
                                    Verena Patterer, 
                                
                                    Susanne Schnittger, 
                                
                                    Wolfgang Kern
                                
                                et al.
                            
                            (2013). 
                            Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1. 
                            Annals of Hematology
                            , 92
                            (6)
                            , 759-769.
                            https://doi.org/10.1007/s00277-013-1695-3
                        

Identifiers

DOI: 10.1007/s00277-013-1695-3